During the past decade, Tangdu Hospital ( Site 0146) conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Tangdu Hospital ( Site 0146)" are "Biliary Tract Carcinoma" (2 trials). Many other conditions were trialed in "Tangdu Hospital ( Site 0146)" in a lesser frequency.

Most popular intervention types in "Tangdu Hospital ( Site 0146)" are "Biological" (2 trials) and "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "Cisplatin" (2 trials), "Gemcitabine" (2 trials), "Pembrolizumab" (2 trials) and "Placebo" (2 trials). Other intervention names were less common.

The vast majority of trials in "Tangdu Hospital ( Site 0146)" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Tangdu Hospital ( Site 0146)". undefined are not yet recruiting, undefined are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in Tangdu Hospital ( Site 0146), undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Tangdu Hospital ( Site 0146), 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".